264 related articles for article (PubMed ID: 36625657)
41. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
[TBL] [Abstract][Full Text] [Related]
42. Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial.
Madariaga MLL; Guthmiller JJ; Schrantz S; Jansen MO; Christensen C; Kumar M; Prochaska M; Wool G; Durkin-Celauro A; Oh WH; Trockman L; Vigneswaran J; Keskey R; Shaw DG; Dugan H; Zheng NY; Cobb M; Utset H; Wang J; Stovicek O; Bethel C; Matushek S; Giurcanu M; Beavis KG; di Sabato D; Meltzer D; Ferguson MK; Kress JP; Shanmugarajah K; Matthews JB; Fung JF; Wilson PC; Alverdy JC; Donington JS
J Intern Med; 2021 Apr; 289(4):559-573. PubMed ID: 33034095
[TBL] [Abstract][Full Text] [Related]
43. Endemic Coronavirus Infections are Associated with Strong Homotypic Immunity in a US Cohort of Children from Birth to 4 Years.
Morrow AL; Payne DC; Conrey SC; McMorrow M; McNeal MM; Niu L; Burrell AR; Schlaudecker EP; Mattison C; Burke RM; DeFranco E; Teoh Z; Wrammert J; Atherton LJ; Thornburg NJ; Staat MA
J Pediatric Infect Dis Soc; 2024 May; 13(5):265-273. PubMed ID: 38442245
[TBL] [Abstract][Full Text] [Related]
44. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
Benner SE; Patel EU; Laeyendecker O; Pekosz A; Littlefield K; Eby Y; Fernandez RE; Miller J; Kirby CS; Keruly M; Klock E; Baker OR; Schmidt HA; Shrestha R; Burgess I; Bonny TS; Clarke W; Caturegli P; Sullivan D; Shoham S; Quinn TC; Bloch EM; Casadevall A; Tobian AAR; Redd AD
J Infect Dis; 2020 Nov; 222(12):1974-1984. PubMed ID: 32910175
[TBL] [Abstract][Full Text] [Related]
45. Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
Bradfute SB; Hurwitz I; Yingling AV; Ye C; Cheng Q; Noonan TP; Raval JS; Sosa NR; Mertz GJ; Perkins DJ; Harkins MS
J Infect Dis; 2020 Oct; 222(10):1620-1628. PubMed ID: 32779705
[TBL] [Abstract][Full Text] [Related]
46. Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial.
Bégin P; Callum J; Heddle NM; Cook R; Zeller MP; Tinmouth A; Fergusson DA; Cushing MM; Glesby MJ; Chassé M; Devine DV; Robitalle N; Bazin R; Shehata N; Finzi A; McGeer A; Scales DC; Schwartz L; Turgeon AF; Zarychanski R; Daneman N; Carl R; Amorim L; Gabe C; Ellis M; Sachais BS; Loftsgard KC; Jamula E; Carruthers J; Duncan J; Lucier K; Li N; Liu Y; Armali C; Kron A; Modi D; Auclair MC; Cerro S; Avram M; Arnold DM
Trials; 2021 May; 22(1):323. PubMed ID: 33947446
[TBL] [Abstract][Full Text] [Related]
47. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
Joyner MJ; Carter RE; Senefeld JW; Klassen SA; Mills JR; Johnson PW; Theel ES; Wiggins CC; Bruno KA; Klompas AM; Lesser ER; Kunze KL; Sexton MA; Diaz Soto JC; Baker SE; Shepherd JRA; van Helmond N; Verdun NC; Marks P; van Buskirk CM; Winters JL; Stubbs JR; Rea RF; Hodge DO; Herasevich V; Whelan ER; Clayburn AJ; Larson KF; Ripoll JG; Andersen KJ; Buras MR; Vogt MNP; Dennis JJ; Regimbal RJ; Bauer PR; Blair JE; Paneth NS; Fairweather D; Wright RS; Casadevall A
N Engl J Med; 2021 Mar; 384(11):1015-1027. PubMed ID: 33523609
[TBL] [Abstract][Full Text] [Related]
48. Human seasonal coronavirus neutralization and COVID-19 severity.
Wells DA; Cantoni D; Mayora-Neto M; Genova CD; Sampson A; Ferrari M; Carnell G; Nadesalingam A; Smith P; Chan A; Raddi G; Castillo-Olivares J; Baxendale H; Temperton N; Heeney JL
J Med Virol; 2022 Oct; 94(10):4820-4829. PubMed ID: 35705514
[TBL] [Abstract][Full Text] [Related]
49. Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
Sturek JM; Thomas TA; Gorham JD; Sheppard CA; Raymond AH; Petros De Guex K; Harrington WB; Barros AJ; Madden GR; Alkabab YM; Lu DY; Liu Q; Poulter MD; Mathers AJ; Thakur A; Schalk DL; Kubicka EM; Lum LG; Heysell SK
Microbiol Spectr; 2022 Feb; 10(1):e0256021. PubMed ID: 35196802
[TBL] [Abstract][Full Text] [Related]
50. Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination.
Amanat F; Clark J; Carreño JM; Strohmeier S; Yellin T; Meade PS; Bhavsar D; Muramatsu H; Sun W; Coughlan L; Pardi N; Krammer F
J Virol; 2023 Mar; 97(3):e0166422. PubMed ID: 36779758
[TBL] [Abstract][Full Text] [Related]
51. Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response.
Lin CY; Wolf J; Brice DC; Sun Y; Locke M; Cherry S; Castellaw AH; Wehenkel M; Crawford JC; Zarnitsyna VI; Duque D; Allison KJ; Allen EK; Brown SA; Mandarano AH; Estepp JH; ; Taylor C; Molina-Paris C; Schultz-Cherry S; Tang L; Thomas PG; McGargill MA
Cell Host Microbe; 2022 Jan; 30(1):83-96.e4. PubMed ID: 34965382
[TBL] [Abstract][Full Text] [Related]
52. An overview on the seven pathogenic human coronaviruses.
Kesheh MM; Hosseini P; Soltani S; Zandi M
Rev Med Virol; 2022 Mar; 32(2):e2282. PubMed ID: 34339073
[TBL] [Abstract][Full Text] [Related]
53. Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19.
Ripoll JG; Tulledge-Scheitel SM; Stephenson AA; Ford S; Pike ML; Gorman EK; Hanson SN; Juskewitch JE; Miller AJ; Zaremba S; Ovrom EA; Razonable RR; Ganesh R; Hurt RT; Fischer EN; Derr AN; Eberle MR; Larsen JJ; Carney CM; Theel ES; Parikh SA; Kay NE; Joyner MJ; Senefeld JW
mBio; 2024 May; 15(5):e0040024. PubMed ID: 38602414
[TBL] [Abstract][Full Text] [Related]
54. Coronavirus HKU1 and other coronavirus infections in Hong Kong.
Lau SK; Woo PC; Yip CC; Tse H; Tsoi HW; Cheng VC; Lee P; Tang BS; Cheung CH; Lee RA; So LY; Lau YL; Chan KH; Yuen KY
J Clin Microbiol; 2006 Jun; 44(6):2063-71. PubMed ID: 16757599
[TBL] [Abstract][Full Text] [Related]
55. SARS-CoV-2 antibody changes in patients receiving COVID-19 convalescent plasma from normal and vaccinated donors.
Leon J; Merrill AE; Rogers K; Kurt J; Dempewolf S; Ehlers A; Jackson JB; Knudson CM
Transfus Apher Sci; 2022 Apr; 61(2):103326. PubMed ID: 34862140
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.
Senefeld JW; Franchini M; Mengoli C; Cruciani M; Zani M; Gorman EK; Focosi D; Casadevall A; Joyner MJ
JAMA Netw Open; 2023 Jan; 6(1):e2250647. PubMed ID: 36633846
[TBL] [Abstract][Full Text] [Related]
57. Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity.
Brown JA; Hauser A; Abela IA; Pasin C; Epp S; Mohloanyane T; Nsakala BL; Trkola A; Labhardt ND; Kouyos RD; Günthard HF
J Infect Dis; 2023 Oct; 228(8):1042-1054. PubMed ID: 37261930
[TBL] [Abstract][Full Text] [Related]
58. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
59. Early Convalescent Plasma for High-Risk Outpatients with Covid-19.
Korley FK; Durkalski-Mauldin V; Yeatts SD; Schulman K; Davenport RD; Dumont LJ; El Kassar N; Foster LD; Hah JM; Jaiswal S; Kaplan A; Lowell E; McDyer JF; Quinn J; Triulzi DJ; Van Huysen C; Stevenson VLW; Yadav K; Jones CW; Kea B; Burnett A; Reynolds JC; Greineder CF; Haas NL; Beiser DG; Silbergleit R; Barsan W; Callaway CW;
N Engl J Med; 2021 Nov; 385(21):1951-1960. PubMed ID: 34407339
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
